• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT SOLO VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT SOLO VASCULAR STENT SYSTEM Back to Search Results
Model Number EX072003CL
Device Problems Fracture (1260); Material Torqued (2980); Material Twisted/Bent (2981)
Patient Problems Claudication (2550); No Known Impact Or Consequence To Patient (2692)
Event Date 01/08/2018
Event Type  Injury  
Manufacturer Narrative
No medical records or no medical images have been made available to the manufacturer; however a photo was provided and a photo review will be performed.As the lot number for the device was not provided, a manufacturing review could not be performed.The device has not been returned to the manufacturer for evaluation to date.The investigation of the reported event is currently underway the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that approximately three months post stent placement in the popliteal artery, the stent allegedly had multiple fractures.It was further reported, the patient returned with reoccurring symptoms (claudication) which may have required medical intervention.Current patient status is unknown.
 
Manufacturer Narrative
Manufacturing review: the lot number was not reported.A review of lot records could not be performed.It was therefore not known whether the reported issue was a potential manufacturing related issue.Investigation summary: based on the images provided it was confirmed that two stents had been placed with overlapping technique and that the stent in distal position was found twisted and fractured.A detailed description of the fracture was not possible due to poor image quality.Potential factors that could have led or contributed to the reported event have been evaluated.Based on the images provided, the evaluation was closed as confirmed for stent twisting.The twisting of this kind of stent is caused by interactions of various use related and anatomical factors with the given stent design.Based on the information available, a definite root cause could not be identified.Labeling review: in reviewing the applicable labeling for this product it was found that the instructions for use sufficiently address the potential risk of a stent twisting and subsequent fracture.The ifu closely describes the stent deployment procedure.The ifu states: 'confirm that the introducer sheath is secure and will not move during deployment (.) the second hand should be used to support the stent delivery system.Gently hold the stability sheath at or proximal to the orange marking and maintain it straight and under tension throughout the procedure (.) do not constrict the delivery system during stent deployment (.) initiate stent deployment by pushing the trigger.Six micro-triggers result in one full trigger.While using fluoroscopy, maintain position of the distal and proximal stent radiopaque markers relative to the targeted site.Continue pushing the trigger until the distal end of the stent obtains complete wall apposition.With the distal end of the stent apposing the vessel wall, final deployment can be continued with full triggers.Deployment of the stent is complete when the proximal stent radiopaque markers appose the vessel wall.Pre- and post dilation was found to be addressed: 'predilation of the lesion should be performed using standard techniques.', and 'post stent expansion with a pta catheter is recommended.' (b)(4).
 
Event Description
It was reported that approximately three months post overlapping stent placement in the popliteal/ femoral artery, the stent in distal position allegedly had multiple fractures.It was further reported, the patient returned with reoccurring symptoms (claudication) which may have required medical intervention.Current patient status is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT SOLO VASCULAR STENT SYSTEM
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key7249160
MDR Text Key99303957
Report Number9681442-2018-00011
Device Sequence Number1
Product Code NIP
UDI-Device Identifier04049519004402
UDI-Public(01)04049519004402
Combination Product (y/n)N
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 03/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberEX072003CL
Device Catalogue NumberEX072003CL
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/11/2018
Initial Date FDA Received02/07/2018
Supplement Dates Manufacturer Received03/08/2018
Supplement Dates FDA Received03/09/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age62 YR
-
-